These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28319737)

  • 1. Relationship between C9orf72 repeat size and clinical phenotype.
    Van Mossevelde S; van der Zee J; Cruts M; Van Broeckhoven C
    Curr Opin Genet Dev; 2017 Jun; 44():117-124. PubMed ID: 28319737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic models of C9orf72: what is toxic?
    Moens TG; Partridge L; Isaacs AM
    Curr Opin Genet Dev; 2017 Jun; 44():92-101. PubMed ID: 28364657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion.
    Van Mossevelde S; van der Zee J; Gijselinck I; Sleegers K; De Bleecker J; Sieben A; Vandenberghe R; Van Langenhove T; Baets J; Deryck O; Santens P; Ivanoiu A; Willems C; Bäumer V; Van den Broeck M; Peeters K; Mattheijssens M; De Jonghe P; Cras P; Martin JJ; Cruts M; De Deyn PP; Engelborghs S; Van Broeckhoven C;
    JAMA Neurol; 2017 Apr; 74(4):445-452. PubMed ID: 28192553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers.
    DeJesus-Hernandez M; Finch NA; Wang X; Gendron TF; Bieniek KF; Heckman MG; Vasilevich A; Murray ME; Rousseau L; Weesner R; Lucido A; Parsons M; Chew J; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; de Boer J; Asmann YW; Petrucelli L; Boylan KB; Dickson DW; van Blitterswijk M; Rademakers R
    Acta Neuropathol; 2017 Aug; 134(2):255-269. PubMed ID: 28508101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Genetics of
    Gijselinck I; Cruts M; Van Broeckhoven C
    Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28130313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation age-acceleration is associated with disease duration and age at onset in C9orf72 patients.
    Zhang M; Tartaglia MC; Moreno D; Sato C; McKeever P; Weichert A; Keith J; Robertson J; Zinman L; Rogaeva E
    Acta Neuropathol; 2017 Aug; 134(2):271-279. PubMed ID: 28439722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers.
    Fournier C; Barbier M; Camuzat A; Anquetil V; Lattante S; Clot F; Cazeneuve C; Rinaldi D; Couratier P; Deramecourt V; Sabatelli M; Belliard S; Vercelletto M; Forlani S; Jornea L; ; ; Leguern E; Brice A; Le Ber I
    Neurobiol Aging; 2019 Feb; 74():234.e1-234.e8. PubMed ID: 30337192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases.
    Dedeene L; Van Schoor E; Ospitalieri S; Ronisz A; Weishaupt JH; Otto M; Ludolph AC; Scheuerle A; Vandenberghe R; Van Damme P; Poesen K; Thal DR
    Acta Neuropathol; 2020 Nov; 140(5):777-781. PubMed ID: 32862270
    [No Abstract]   [Full Text] [Related]  

  • 10. von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion.
    Yang Y; Halliday GM; Hodges JR; Tan RH
    J Alzheimers Dis; 2017; 58(3):701-709. PubMed ID: 28482638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
    Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
    Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients.
    König T; Wurm R; Parvizi T; Silvaieh S; Hotzy C; Cetin H; Klotz S; Gelpi E; Bancher C; Benke T; Dal-Bianco P; Defrancesco M; Fischer P; Marksteiner J; Sutterlüty H; Ransmayr G; Schmidt R; Zimprich A; Stögmann E
    Neurobiol Dis; 2022 Dec; 175():105927. PubMed ID: 36379394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond.
    Saracino D; Le Ber I
    Adv Exp Med Biol; 2021; 1281():67-76. PubMed ID: 33433869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the C9ORF72 repeat expansion mutation using human induced pluripotent stem cells.
    Selvaraj BT; Livesey MR; Chandran S
    Brain Pathol; 2017 Jul; 27(4):518-524. PubMed ID: 28585384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.
    Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Engelborghs S; De Bleecker J; Ivanoiu A; Deryck O; Edbauer D; Zhang M; Heeman B; Bäumer V; Van den Broeck M; Mattheijssens M; Peeters K; Rogaeva E; De Jonghe P; Cras P; Martin JJ; de Deyn PP; Cruts M; Van Broeckhoven C
    Mol Psychiatry; 2016 Aug; 21(8):1112-24. PubMed ID: 26481318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proline/arginine dipeptide repeat polymers derail protein folding in amyotrophic lateral sclerosis.
    Babu M; Favretto F; de Opakua AI; Rankovic M; Becker S; Zweckstetter M
    Nat Commun; 2021 Jun; 12(1):3396. PubMed ID: 34099711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of five induced pluripotent stem cells lines from four members of the same family carrying a C9orf72 repeat expansion and one wild-type member.
    Lattuada C; Santangelo S; Peverelli S; McGoldrick P; Rogaeva E; Zinman L; Haase G; Géli V; Silani V; Robertson J; Ratti A; Bossolasco P
    Stem Cell Res; 2023 Feb; 66():102998. PubMed ID: 36528014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation.
    Takada LT; Pimentel ML; Dejesus-Hernandez M; Fong JC; Yokoyama JS; Karydas A; Thibodeau MP; Rutherford NJ; Baker MC; Lomen-Hoerth C; Rademakers R; Miller BL
    Arch Neurol; 2012 Sep; 69(9):1149-53. PubMed ID: 22964910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unravelling the clinical spectrum and the role of repeat length in
    van der Ende EL; Jackson JL; White A; Seelaar H; van Blitterswijk M; Van Swieten JC
    J Neurol Neurosurg Psychiatry; 2021 May; 92(5):502-509. PubMed ID: 33452054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy.
    Yang M; Liang C; Swaminathan K; Herrlinger S; Lai F; Shiekhattar R; Chen JF
    Sci Adv; 2016 Sep; 2(9):e1601167. PubMed ID: 27617292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.